JSJ Pharmaceuticals, Inc. Introduces Two Additional Options for Managing Acne
Published: Oct 23, 2007
CHARLESTON, S.C., Oct. 23 /PRNewswire/ -- JSJ Pharmaceuticals is proud to introduce patients and physicians to two more options for the management of inflammatory and non-inflammatory acne lesions. Inova 8(TM) (benzoyl peroxide 8%) is ideal for use as monotherapy or for use with other acne treatments, providing clinicians with prescribing flexibility while treating acne. Inova 8/2 ACT (Acne Control Therapy) bundles together one box of benzoyl peroxide 8% pads and one box of salicylic acid 2% pads. The comedolytic activity of salicylic acid and the p.acnes control of benzoyl peroxide give a novel approach to treating acne.
The Easy Pad(TM) technology allows each patient a single unit dose that works with the lifestyle of each patient. This pad system is great for adolescent and post-adolescent patients who are active and always on-the-go. Inova Easy Pad(TM) leave-on formulation is designed for convenient use at home or on-the-go.
About JSJ Pharmaceuticals:
JSJ Pharmaceuticals is a growing specialty pharmaceutical company focused on the development and commercialization of prescriptive products to meet the diverse needs of patients suffering from a wide range of dermatological conditions. More information can be found about JSJ Pharmaceuticals at http://www.jsjpharm.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com
CONTACT: Media, Jon Knowles, +1-843-965-8333 ext. 104,
Web site: http://www.jsjpharm.com/